Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Mol Ther. 2003 Oct;5(5):489-94.

    Update on gene therapy for cystic fibrosis.

    Source

    Department of Gene Therapy, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, Manresa Road, London, SW3 6LR, UK. u.griesenbach@imperial.ac.uk

    Abstract

    Cystic fibrosis (CF) is a monogenic autosomal recessive disease. Although several organs are affected, severe lung disease is the cause of most morbidity and mortality in CF individuals. The first clinical trials in CF patients were carried out in 1993, and to date, 29 trial protocols have been published. Although proof-of-principle for gene transfer to the lung has been established, efficiency is generally low. Steady progress has been made over the last two years and key papers, including recent advances in viral and nonviral gene transfer agents, will be reviewed here.

    PMID:
    14601517
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk